Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress

被引:114
作者
Winokur, ST
Barrett, K
Martin, JH
Forrester, JR
Simon, M
Tawil, R
Chung, SA
Masny, PS
Figlewicz, DA
机构
[1] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA
[2] Univ Rochester, Dept Neurol, Rochester, NY USA
[3] Univ Rochester, Dept Neurobiol & Anat, Rochester, NY USA
关键词
facioscapulohumeral muscular dystrophy; p21; oxidative stress; microarray expression analysis;
D O I
10.1016/S0960-8966(02)00284-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Facioscapulohumeral muscular dystrophy is an autosomal dominant disorder resulting from an unusual genetic mechanism. The mutation, a deletion of 3.3 kb subtelomeric repeats, appears to disrupt the regional regulation of 4q35 gene expression. The specific gene(s) responsible for facioscapulohumeral muscular dystrophy have not been identified. However, the 'vacuolar/necrotic' phenotype exhibited by facioscapulohumeral muscular dystrophy myoblasts suggests that aberrant gene expression occurs early in facioscapulohumeral muscular dystrophy muscle development. In order to test this hypothesis, global gene expression profiling and in vitro characterization of facioscapulohumeral muscular dystrophy and control myoblasts were carried out. Genes involved in several cellular processes such as oxidative stress were found to be dysregulated. In vitro studies confirmed this susceptibility to oxidative stress, as proliferative stage facioscapulohumeral muscular dystrophy myoblasts exhibit greatly reduced viability when exposed to the oxidative stressor paraquat. This effect was not seen in either normal or disease control myoblasts, or in any of the cell lines upon differentiation to multinucleated myotubes. lmmunocytochemical studies of the cyclin dependent kinase inhibitor p21 demonstrated increased expression in facioscapulohumeral muscular dystrophy myoblasts, suggesting an early cell cycle arrest. Another process distinguishing facioscapulohumeral muscular dystrophy from controls involves the transcription of extracellular matrix components. Expression of elastin, decorin, lumican and the extracellular matrix remodeling factor TIMP3 were reduced in facioscapulohumeral muscular dystrophy myoblasts. These studies suggest that facioscapulohumeral muscular dystrophy muscular dystrophy results from a defect in early myogenesis, manifested as increased susceptibility to oxidative stress, morphological aberrations and early cell cycle arrest. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:322 / 333
页数:12
相关论文
共 34 条
[1]  
ARAHATA K, 1995, MUSCLE NERVE, pS56
[2]   Active genes in junk DNA?: Characterization of DUX genes embedded within 3.3 kb repeated elements [J].
Beckers, MC ;
Gabriëls, J ;
van der Maarel, S ;
De Vriese, A ;
Frants, RR ;
Collen, D ;
Belayew, A .
GENE, 2001, 264 (01) :51-57
[3]   HIGH-RESOLUTION FLUORESCENCE IN-SITU HYBRIDIZATION TO LINEARLY EXTENDED DNA VISUALLY MAPS A TANDEM REPEAT ASSOCIATED WITH FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY IMMEDIATELY ADJACENT TO THE TELOMERE OF 4Q [J].
BENGTSSON, U ;
ALTHERR, MR ;
WASMUTH, JJ ;
WINOKUR, ST .
HUMAN MOLECULAR GENETICS, 1994, 3 (10) :1801-1805
[4]   Options available - from start to finish - for obtaining expression data by microarray [J].
Bowtell, DDL .
NATURE GENETICS, 1999, 21 (Suppl 1) :25-32
[5]   Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies [J].
Choi, YC ;
Dalakas, MC .
NEUROLOGY, 2000, 54 (01) :65-71
[6]  
FIGLEWICZ DA, 2002, FACIOSCAPULOHUMERAL
[7]   Epilepsy and mental retardation in a subset of early onset 4q35-facioscapulohumeral muscular dystrophy [J].
Funakoshi, M ;
Goto, K ;
Arahata, K .
NEUROLOGY, 1998, 50 (06) :1791-1794
[8]  
GUO K, 1995, MOL CELL BIOL, V15, P3823
[9]   CORRELATION OF TERMINAL CELL-CYCLE ARREST OF SKELETAL-MUSCLE WITH INDUCTION OF P21 BY MYOD [J].
HALEVY, O ;
NOVITCH, BG ;
SPICER, DB ;
SKAPEK, SX ;
RHEE, J ;
HANNON, GJ ;
BEACH, D ;
LASSAR, AB .
SCIENCE, 1995, 267 (5200) :1018-1021
[10]   The glutathione S-Transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance [J].
Hayes, JD ;
Pulford, DJ .
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1995, 30 (06) :445-600